Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00034125 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
A Phase 3 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00034125 is a Phase 3 study that has completed, run by Eli Lilly and Company.
The verdict
NCT00034125, a Phase 3 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.
Interventions
- DRUG tamoxifen
- DRUG LY353381
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00034125
The ClinicalTrials.gov registry entry for NCT00034125 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tamoxifen is the first listed.
NCT00034125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00034125 about?
NCT00034125 is a clinical study titled "Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.". To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.
What is the current status of trial NCT00034125?
This trial is currently completed. It is a Phase 3 study.
What interventions are being tested in trial NCT00034125?
The interventions under investigation include: tamoxifen (DRUG), LY353381 (DRUG).
Who is sponsoring clinical trial NCT00034125?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.